Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paclitaxel Added to High-Dose Carboplatin and Cyclophosphamide with Stem Cell Support in Metastatic Breast Cancer
NCT00002628Phase 2Unknown
- Sponsor
- Saint Louis University
- Start
- Nov 1994
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of paclitaxel in breast cancer, sponsored by Saint Louis University. Primary endpoint: Maximum Tolerated Dose. Status: unknown.
02
Drugs
paclitaxel
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00002628.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002628.